[go: up one dir, main page]

AR108014A1 - Vacuna universal para enfermedades virales y método de vacunación - Google Patents

Vacuna universal para enfermedades virales y método de vacunación

Info

Publication number
AR108014A1
AR108014A1 ARP170100911A ARP170100911A AR108014A1 AR 108014 A1 AR108014 A1 AR 108014A1 AR P170100911 A ARP170100911 A AR P170100911A AR P170100911 A ARP170100911 A AR P170100911A AR 108014 A1 AR108014 A1 AR 108014A1
Authority
AR
Argentina
Prior art keywords
virus
polypeptides
peptides
proteins
viral diseases
Prior art date
Application number
ARP170100911A
Other languages
English (en)
Inventor
Ana Romo
Emmanuel Grard Etienne Regulier
Rodolfo Csar Bellinzoni
Original Assignee
Biogenesis Bago Uruguay S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenesis Bago Uruguay S A filed Critical Biogenesis Bago Uruguay S A
Publication of AR108014A1 publication Critical patent/AR108014A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Reivindicación 1: Una formulación de vacuna capaz de inducir protección cruzada contra diferentes serotipos o cepas de un virus, que comprende partículas virales inactivadas y al menos uno de los siguientes componentes: a) polinucleótidos que codifican péptidos, polipéptidos o proteínas de dicho virus; b) péptidos o polipéptidos sintéticos de dicho virus; c) péptidos, polipéptidos o proteínas recombinantes de dicho virus; d) VLPs de dicho virus; e) VLPs derivadas de otros virus que presentan péptidos, polipéptidos o proteínas recombinantes de dicho virus; y f) péptidos, polipéptidos o proteínas como carriers o adyuvantes moleculares que están o no fusionados a cualquiera de los componentes de (b) a (e).
ARP170100911A 2016-04-11 2017-04-10 Vacuna universal para enfermedades virales y método de vacunación AR108014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662320852P 2016-04-11 2016-04-11

Publications (1)

Publication Number Publication Date
AR108014A1 true AR108014A1 (es) 2018-07-11

Family

ID=60041433

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100911A AR108014A1 (es) 2016-04-11 2017-04-10 Vacuna universal para enfermedades virales y método de vacunación

Country Status (9)

Country Link
US (2) US10940196B2 (es)
EP (1) EP3443097A4 (es)
KR (1) KR20180132742A (es)
CN (1) CN109196104B (es)
AR (1) AR108014A1 (es)
BR (1) BR112018070634A2 (es)
TW (1) TWI763662B (es)
UY (1) UY37198A (es)
WO (1) WO2017178945A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3909970A1 (en) * 2020-05-14 2021-11-17 Consejo Superior De Investigaciones Científicas Peptide vaccines for the prevention of foot-and-mouth disease
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN111978380A (zh) * 2020-09-02 2020-11-24 天康生物股份有限公司 野生型气肿疽梭菌细胞毒素a及其制备方法、应用和疫苗
CN114748617B (zh) * 2022-03-24 2024-04-16 华南农业大学 一种大口黑鲈虹彩病毒的亚单位疫苗及其制备方法和应用
CN114874338B (zh) * 2022-05-18 2024-04-12 华中农业大学 一种口蹄疫病毒纳米颗粒及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245217C (zh) * 2001-02-15 2006-03-15 雷吉斯特印度科学院 一种包含dna疫苗和灭活狂犬病毒的疫苗制剂
CN1408434A (zh) * 2002-09-16 2003-04-09 复旦大学 抗家畜口蹄疫的多肽和dna联合疫苗及其制备方法
AR044603A1 (es) * 2004-06-03 2005-09-21 Consejo Nac Invest Cient Tec Proteinas quimericas aisladas de lumazina sintetasa modificada para la presentacion multiple de moleculas y sus aplicaciones
US9109014B2 (en) * 2009-11-02 2015-08-18 The Trustees Of The University Of Pennsylvania Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
CN101948811B (zh) * 2010-08-18 2013-01-09 中国农业科学院兰州兽医研究所 用反向遗传操作拓展口蹄疫疫苗株抗原谱及疫苗制备方法
CN102168088B (zh) 2010-12-23 2012-12-26 中国农业科学院兰州兽医研究所 T细胞免疫原基因ti及其在口蹄疫蛋白亚单位疫苗和灭活疫苗中的应用
BR112015023651A2 (pt) * 2013-03-15 2017-10-24 Novavax Inc expressão aumentada de proteínas de picornavírus
CA2913702C (en) * 2013-05-27 2023-08-01 Inmunova S.A. Chimeras of brucella lumazine synthase and beta subunit of ab5 toxins
CN105056227B (zh) * 2015-07-21 2017-12-29 复旦大学 一种抗口蹄疫病毒的类病毒粒子vlp疫苗及其制备方法

Also Published As

Publication number Publication date
US10940196B2 (en) 2021-03-09
EP3443097A4 (en) 2020-04-22
TW201740973A (zh) 2017-12-01
CN109196104B (zh) 2023-01-31
BR112018070634A2 (pt) 2019-02-05
US20190142926A1 (en) 2019-05-16
EP3443097A1 (en) 2019-02-20
CN109196104A (zh) 2019-01-11
WO2017178945A1 (en) 2017-10-19
KR20180132742A (ko) 2018-12-12
UY37198A (es) 2017-11-30
TWI763662B (zh) 2022-05-11
US20210187096A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
CL2019000993A1 (es) Meganucleasas diseñadas específicamente para el reconocimiento de secuencias en el genoma del virus de la hepatitis b.
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
EP4104854A3 (en) Multivalent vaccines for rabies virus and coronaviruses
CL2019000704A1 (es) Vectores de adenovirus canino.
EA201990085A1 (ru) Рационально разработанный аттенуированный штамм вируса африканской лихорадки свиней для защиты от заражения исходным вирусным изолятом georgia 2007
JOP20190088A1 (ar) نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
CL2019002964A1 (es) Vacunas contra el gallid herpesvirus 3 recombinante que codifican antígenos patogénicos aviares heterólogos.
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
EA201890042A1 (ru) Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva)
BR112017024283A8 (pt) Vacinas contra a dengue
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
PE20170429A1 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
PH12017500419B1 (en) Recoded arbovirus and vaccines
AR095425A1 (es) Vacuna, uso y procedimiento para prevenir una infección por picornavirus
MX373809B (es) Virus de la viruela porcina recombinante y vacunas.
MX2019007924A (es) Vacunas contra la influenza.
MX2018000023A (es) Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina.
MX394998B (es) Virus de vacuna del sindrome respiratorio y reproductivo porcino.
BR112019008584A2 (pt) vacinas de mosaico para vírus de doença de pé-e-boca de sorotipo a
AR094912A1 (es) Vacuna contra el virus de la leucemia bovina
EA202191862A2 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
EA201790506A1 (ru) Филовирусная вакцина на основе рекомбинантного модифицированного вируса осповакцины анкара (mva)

Legal Events

Date Code Title Description
FB Suspension of granting procedure